CUPR - Bathi resik saben saham (EPS TTM) Cuprina Holdings Ltd

Cuprina Holdings (Cayman) Ltd (CUPR) dominates the wound biotherapy niche, leveraging unique methods to maintain significant pricing power. This chart on GURU.Markets illustrates how the trailing 12-month earnings per share trend reacts to this success, with the latest figure standing at -1.34. The business relies on growing demand from an aging population and complete resilience to any economic crises.
Rincian analitis perusahaan Cuprina Holdings Ltd (CUPR)

The expansion of larval therapy and the demand for biologics in the US directly determine the financial performance of Cuprina Holdings (Cayman) Ltd (CUPR). These operational successes translate into net income distributed per share. This trailing twelve-month (TTM) metric eliminates speculative noise, capturing the actual intrinsic value of the business. The stability of the trend lines signals market equilibrium. Analyzing the TTM annual earnings per share allows for the timely detection of margin compression.